# case_10_node_2

## Outcome

- Run status: complete; final source: LLM.
- Target: furmonertinib monotherapy after intracranial progression on osimertinib in EGFR L858R/T790M metastatic lung adenocarcinoma.
- The final answer explicitly stated that no cutoff-valid direct evidence was retrieved and made a conservative low-confidence prediction from cross-resistance reasoning and model prior.

## Component audit

- Runtime was 1,019.6 seconds. The Agent loop used 915.9 seconds; 10 rerank calls alone used 683.8 seconds and 83,192 tokens. Several rerank responses exhausted the 6,000-token output allowance without producing a complete structured result, causing retries and fallback work.
- Evidence Review accepted 12/12 candidates as `analog_support`. Eleven had a different target entity and all twelve were low relevance under the trajectory audit. This is evidence-volume inflation rather than useful support.
- AnswerMemory atomicity held: twelve evidence statements remained twelve claims rather than merging populations, drugs and outcomes.
- Context correctly kept direct findings empty, but still retained ten weak findings and twelve evidence identifiers. These could not support a target-specific prediction and increased the final prompt to 15,903 characters.
- Generate cited no retrieved evidence and honestly declared the direct-evidence gap. The prediction therefore came mainly from model prior; retrieval added latency and context burden without a traceable target-specific benefit.

## Classification

- Repeated general issue: Evidence Review admits weak, entity-mismatched material merely because it is medically related.
- Repeated efficiency issue: rerank structured outputs are too verbose for the allowed output budget; incomplete calls dominate latency.
- Repeated context issue: declaring evidence weak is insufficient if all weak evidence is still forwarded downstream.
- Skill candidate: applicability grading must reject analogs that fail the intervention/regimen and resistance-setting dimensions, then retain only a small number of non-redundant nearest analogs.
- Engineering candidate: constrain rerank output fields/reasoning and enforce a per-step rerank-call quota; serial execution alone improves stability but does not reduce total work.
